The results of the present study may be beneficial for the treatment of patients with ESCC, and new drugs aimed at blocking the VEGF-C/VEGFR-3 axis may be useful for limiting lymph node metastasis. This evidence concerns the gene FLT4 and esophageal squamous cell carcinoma.